Filing Details
- Accession Number:
- 0000899243-19-013257
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-05-13 17:01:50
- Reporting Period:
- 2019-05-09
- Accepted Time:
- 2019-05-13 17:01:50
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1563880 | Trevi Therapeutics Inc. | TRVI | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1448914 | Thomas Michael Heffernan | C/O Trevi Therapeutics, Inc. 195 Church Street, 14Th Floor New Haven CT 06510 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-05-09 | 3,851 | $0.00 | 3,851 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2019-05-09 | 2,500 | $10.00 | 6,351 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Direct | |
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series C Preferred Stock | Disposition | 2019-05-09 | 34,247 | $0.00 | 3,851 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Direct |
Footnotes
- On May 9, 2019, the Series C Preferred Stock, and the dividends that had accrued thereon to date, converted into Common Stock on a 9.5-for-one basis without payment of further consideration automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.
Billionaire Hedge Funds
